Licença compulsória para medicamentos como política pública: o caso do anti-retroviral efavirenz
Autor(a) principal: | |
---|---|
Data de Publicação: | 2010 |
Tipo de documento: | Dissertação |
Idioma: | por |
Título da fonte: | Repositório Institucional do FGV (FGV Repositório Digital) |
Texto Completo: | http://hdl.handle.net/10438/6559 |
Resumo: | The scope of this study is to evaluate the implementation process of the Compulsory License in the case of the antiretroviral efavirenz. This research is descriptive in nature and the medium of investigation was the case study. It was conducted during the months of October through December 2009 with semi-structured interviews containing open-ended questions with a group of Public Health policy makers and managers residing in the states of Rio de Janeiro, Sao Paulo and the Federal District who participated in the compulsory license process. These individuals were allowed to express themselves without any constraints in such a way that they could produce discourses. The Collective Subject Discourse (CSD) technique was then used for analysis of the discourses. The results revealed that Brazil has the technological capability to develop and produce antiretrovirals within a reasonably short period of time. The results further showed that the Compulsory License helped to curb spending on antiretrovirals and that the measure can be used to ensure access by the public to high-cost and strategic antiretroviral drugs for the Brazilian public health service (Unified Health System – SUS) in an environment with limited funds, whenever an impasse is reached in negotiations for price reductions with transnational pharmaceutical laboratories. |
id |
FGV_e89c49b82d8a3fcaab71d63a39a0945b |
---|---|
oai_identifier_str |
oai:repositorio.fgv.br:10438/6559 |
network_acronym_str |
FGV |
network_name_str |
Repositório Institucional do FGV (FGV Repositório Digital) |
repository_id_str |
3974 |
spelling |
Hoirisch, CláudiaEscolas::EBAPETeixeira, Sônia Maria FleuryChamas, Claudia InêsSaravia, Enrique J.2010-05-14T12:29:32Z2010-05-14T12:29:32Z2010-03-24HOIRISCH, Cláudia. Licença compulsória para medicamentos como política pública: o caso do anti-retroviral efavirenz. Dissertação (Mestrado em Gestão Empresarial) - FGV - Fundação Getúlio Vargas, Rio de Janeiro, 2010.http://hdl.handle.net/10438/6559The scope of this study is to evaluate the implementation process of the Compulsory License in the case of the antiretroviral efavirenz. This research is descriptive in nature and the medium of investigation was the case study. It was conducted during the months of October through December 2009 with semi-structured interviews containing open-ended questions with a group of Public Health policy makers and managers residing in the states of Rio de Janeiro, Sao Paulo and the Federal District who participated in the compulsory license process. These individuals were allowed to express themselves without any constraints in such a way that they could produce discourses. The Collective Subject Discourse (CSD) technique was then used for analysis of the discourses. The results revealed that Brazil has the technological capability to develop and produce antiretrovirals within a reasonably short period of time. The results further showed that the Compulsory License helped to curb spending on antiretrovirals and that the measure can be used to ensure access by the public to high-cost and strategic antiretroviral drugs for the Brazilian public health service (Unified Health System – SUS) in an environment with limited funds, whenever an impasse is reached in negotiations for price reductions with transnational pharmaceutical laboratories.O objetivo deste estudo é avaliar o processo de implementação da Licença Compulsória no caso do anti-retroviral efavirenz. Esta pesquisa é de caráter descritivo, o meio de investigação foi o estudo de caso e foi conduzido com entrevistas semi-estruturadas contendo questões abertas para um conjunto de atores representativos da área da Saúde Pública que participaram do processo da licença compulsória residentes nos estados do Rio de Janeiro e São Paulo e no Distrito Federal durante os meses de outubro a dezembro de 2009. Permitiu-se que esses indivíduos se expressassem mais ou menos livremente de forma que eles produzissem discursos. Para a análise dos discursos, utilizou-se a técnica do Discurso do Sujeito Coletivo (DSC). Os resultados demonstraram que o Brasil possui capacitação tecnológica para desenvolver e produzir anti-retrovirais em um prazo relativamente curto. Os resultados mostram ainda que a Licença Compulsória ajudou a refrear os gastos com anti-retrovirais e que o instrumento pode ser utilizado para garantir o acesso da população a medicamentos anti-retrovirais de alto custo e estratégicos para o Sistema Único de Saúde em um ambiente de recursos limitados sempre que se chegar a um impasse na negociação para redução de preços com os laboratórios farmacêuticos transnacionais.porLicença compulsóriaEfavirenzTerapia anti-retroviral de alta efetividade (TARV)MedicamentosAcesso a medicamentosOrçamentoCapacitação tecnológicaPropriedade intelectualPatentesCompulsory licensingEfavirenzHighly Active AntiRetroviral Treatment (HAART)DrugsAccess to medicinesBudgetTechnological capabilityIntellectual propertyPatentsBrazilAdministração de empresasPolíticas públicasPatentesMedicamentosPropriedade industrialLicença compulsória para medicamentos como política pública: o caso do anti-retroviral efavirenzinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisreponame:Repositório Institucional do FGV (FGV Repositório Digital)instname:Fundação Getulio Vargas (FGV)instacron:FGVinfo:eu-repo/semantics/openAccessORIGINALCláudia Hoirisch.pdfCláudia Hoirisch.pdfapplication/pdf1193444https://repositorio.fgv.br/bitstreams/52573174-8e73-4767-8224-1f8e831ff7b6/download18921b0201a6008cb606c1dcc39797a0MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-84712https://repositorio.fgv.br/bitstreams/9d0487a2-697f-40cf-87af-05093b5ab97f/download4dea6f7333914d9740702a2deb2db217MD52TEXTCláudia Hoirisch.pdf.txtCláudia Hoirisch.pdf.txtExtracted texttext/plain102876https://repositorio.fgv.br/bitstreams/5ce0667e-0fe7-418a-931c-bb140249826b/downloadf33a98bc8615ba283e947359a1dcbf3bMD57THUMBNAILCláudia Hoirisch.pdf.jpgCláudia Hoirisch.pdf.jpgGenerated Thumbnailimage/jpeg3011https://repositorio.fgv.br/bitstreams/3b134e28-12e3-4128-ba39-ac831ec62daf/download57a8307b2ca767aa36af916d78eb81e8MD5810438/65592023-11-09 02:37:41.022open.accessoai:repositorio.fgv.br:10438/6559https://repositorio.fgv.brRepositório InstitucionalPRIhttp://bibliotecadigital.fgv.br/dspace-oai/requestopendoar:39742023-11-09T02:37:41Repositório Institucional do FGV (FGV Repositório Digital) - Fundação Getulio Vargas (FGV)falseVEVSTU9TIExJQ0VOQ0lBTUVOVE8gUEFSQSBBUlFVSVZBTUVOVE8sIFJFUFJPRFXDh8ODTyBFIERJVlVMR0HDh8ODTwpQw5pCTElDQSBERSBDT05URcOaRE8gw4AgQklCTElPVEVDQSBWSVJUVUFMIEZHViAodmVyc8OjbyAxLjIpCgoxLiBWb2PDqiwgdXN1w6FyaW8tZGVwb3NpdGFudGUgZGEgQmlibGlvdGVjYSBWaXJ0dWFsIEZHViwgYXNzZWd1cmEsIG5vCnByZXNlbnRlIGF0bywgcXVlIMOpIHRpdHVsYXIgZG9zIGRpcmVpdG9zIGF1dG9yYWlzIHBhdHJpbW9uaWFpcyBlL291CmRpcmVpdG9zIGNvbmV4b3MgcmVmZXJlbnRlcyDDoCB0b3RhbGlkYWRlIGRhIE9icmEgb3JhIGRlcG9zaXRhZGEgZW0KZm9ybWF0byBkaWdpdGFsLCBiZW0gY29tbyBkZSBzZXVzIGNvbXBvbmVudGVzIG1lbm9yZXMsIGVtIHNlIHRyYXRhbmRvCmRlIG9icmEgY29sZXRpdmEsIGNvbmZvcm1lIG8gcHJlY2VpdHVhZG8gcGVsYSBMZWkgOS42MTAvOTggZS9vdSBMZWkKOS42MDkvOTguIE7Do28gc2VuZG8gZXN0ZSBvIGNhc28sIHZvY8OqIGFzc2VndXJhIHRlciBvYnRpZG8sIGRpcmV0YW1lbnRlCmRvcyBkZXZpZG9zIHRpdHVsYXJlcywgYXV0b3JpemHDp8OjbyBwcsOpdmlhIGUgZXhwcmVzc2EgcGFyYSBvIGRlcMOzc2l0byBlCmRpdnVsZ2HDp8OjbyBkYSBPYnJhLCBhYnJhbmdlbmRvIHRvZG9zIG9zIGRpcmVpdG9zIGF1dG9yYWlzIGUgY29uZXhvcwphZmV0YWRvcyBwZWxhIGFzc2luYXR1cmEgZG9zIHByZXNlbnRlcyB0ZXJtb3MgZGUgbGljZW5jaWFtZW50bywgZGUKbW9kbyBhIGVmZXRpdmFtZW50ZSBpc2VudGFyIGEgRnVuZMOnw6NvIEdldHVsaW8gVmFyZ2FzIGUgc2V1cwpmdW5jaW9uw6FyaW9zIGRlIHF1YWxxdWVyIHJlc3BvbnNhYmlsaWRhZGUgcGVsbyB1c28gbsOjby1hdXRvcml6YWRvIGRvCm1hdGVyaWFsIGRlcG9zaXRhZG8sIHNlamEgZW0gdmluY3VsYcOnw6NvIMOgIEJpYmxpb3RlY2EgVmlydHVhbCBGR1YsIHNlamEKZW0gdmluY3VsYcOnw6NvIGEgcXVhaXNxdWVyIHNlcnZpw6dvcyBkZSBidXNjYSBlIGRpc3RyaWJ1acOnw6NvIGRlIGNvbnRlw7pkbwpxdWUgZmHDp2FtIHVzbyBkYXMgaW50ZXJmYWNlcyBlIGVzcGHDp28gZGUgYXJtYXplbmFtZW50byBwcm92aWRlbmNpYWRvcwpwZWxhIEZ1bmRhw6fDo28gR2V0dWxpbyBWYXJnYXMgcG9yIG1laW8gZGUgc2V1cyBzaXN0ZW1hcyBpbmZvcm1hdGl6YWRvcy4KCjIuIEEgYXNzaW5hdHVyYSBkZXN0YSBsaWNlbsOnYSB0ZW0gY29tbyBjb25zZXHDvMOqbmNpYSBhIHRyYW5zZmVyw6puY2lhLCBhCnTDrXR1bG8gbsOjby1leGNsdXNpdm8gZSBuw6NvLW9uZXJvc28sIGlzZW50YSBkbyBwYWdhbWVudG8gZGUgcm95YWx0aWVzCm91IHF1YWxxdWVyIG91dHJhIGNvbnRyYXByZXN0YcOnw6NvLCBwZWN1bmnDoXJpYSBvdSBuw6NvLCDDoCBGdW5kYcOnw6NvCkdldHVsaW8gVmFyZ2FzLCBkb3MgZGlyZWl0b3MgZGUgYXJtYXplbmFyIGRpZ2l0YWxtZW50ZSwgcmVwcm9kdXppciBlCmRpc3RyaWJ1aXIgbmFjaW9uYWwgZSBpbnRlcm5hY2lvbmFsbWVudGUgYSBPYnJhLCBpbmNsdWluZG8tc2UgbyBzZXUKcmVzdW1vL2Fic3RyYWN0LCBwb3IgbWVpb3MgZWxldHLDtG5pY29zLCBubyBzaXRlIGRhIEJpYmxpb3RlY2EgVmlydHVhbApGR1YsIGFvIHDDumJsaWNvIGVtIGdlcmFsLCBlbSByZWdpbWUgZGUgYWNlc3NvIGFiZXJ0by4KCjMuIEEgcHJlc2VudGUgbGljZW7Dp2EgdGFtYsOpbSBhYnJhbmdlLCBub3MgbWVzbW9zIHRlcm1vcyBlc3RhYmVsZWNpZG9zCm5vIGl0ZW0gMiwgc3VwcmEsIHF1YWxxdWVyIGRpcmVpdG8gZGUgY29tdW5pY2HDp8OjbyBhbyBww7pibGljbyBjYWLDrXZlbAplbSByZWxhw6fDo28gw6AgT2JyYSBvcmEgZGVwb3NpdGFkYSwgaW5jbHVpbmRvLXNlIG9zIHVzb3MgcmVmZXJlbnRlcyDDoApyZXByZXNlbnRhw6fDo28gcMO6YmxpY2EgZS9vdSBleGVjdcOnw6NvIHDDumJsaWNhLCBiZW0gY29tbyBxdWFscXVlciBvdXRyYQptb2RhbGlkYWRlIGRlIGNvbXVuaWNhw6fDo28gYW8gcMO6YmxpY28gcXVlIGV4aXN0YSBvdSB2ZW5oYSBhIGV4aXN0aXIsCm5vcyB0ZXJtb3MgZG8gYXJ0aWdvIDY4IGUgc2VndWludGVzIGRhIExlaSA5LjYxMC85OCwgbmEgZXh0ZW5zw6NvIHF1ZQpmb3IgYXBsaWPDoXZlbCBhb3Mgc2VydmnDp29zIHByZXN0YWRvcyBhbyBww7pibGljbyBwZWxhIEJpYmxpb3RlY2EKVmlydHVhbCBGR1YuCgo0LiBFc3RhIGxpY2Vuw6dhIGFicmFuZ2UsIGFpbmRhLCBub3MgbWVzbW9zIHRlcm1vcyBlc3RhYmVsZWNpZG9zIG5vCml0ZW0gMiwgc3VwcmEsIHRvZG9zIG9zIGRpcmVpdG9zIGNvbmV4b3MgZGUgYXJ0aXN0YXMgaW50w6lycHJldGVzIG91CmV4ZWN1dGFudGVzLCBwcm9kdXRvcmVzIGZvbm9ncsOhZmljb3Mgb3UgZW1wcmVzYXMgZGUgcmFkaW9kaWZ1c8OjbyBxdWUKZXZlbnR1YWxtZW50ZSBzZWphbSBhcGxpY8OhdmVpcyBlbSByZWxhw6fDo28gw6Agb2JyYSBkZXBvc2l0YWRhLCBlbQpjb25mb3JtaWRhZGUgY29tIG8gcmVnaW1lIGZpeGFkbyBubyBUw610dWxvIFYgZGEgTGVpIDkuNjEwLzk4LgoKNS4gU2UgYSBPYnJhIGRlcG9zaXRhZGEgZm9pIG91IMOpIG9iamV0byBkZSBmaW5hbmNpYW1lbnRvIHBvcgppbnN0aXR1acOnw7VlcyBkZSBmb21lbnRvIMOgIHBlc3F1aXNhIG91IHF1YWxxdWVyIG91dHJhIHNlbWVsaGFudGUsIHZvY8OqCm91IG8gdGl0dWxhciBhc3NlZ3VyYSBxdWUgY3VtcHJpdSB0b2RhcyBhcyBvYnJpZ2HDp8O1ZXMgcXVlIGxoZSBmb3JhbQppbXBvc3RhcyBwZWxhIGluc3RpdHVpw6fDo28gZmluYW5jaWFkb3JhIGVtIHJhesOjbyBkbyBmaW5hbmNpYW1lbnRvLCBlCnF1ZSBuw6NvIGVzdMOhIGNvbnRyYXJpYW5kbyBxdWFscXVlciBkaXNwb3Npw6fDo28gY29udHJhdHVhbCByZWZlcmVudGUgw6AKcHVibGljYcOnw6NvIGRvIGNvbnRlw7pkbyBvcmEgc3VibWV0aWRvIMOgIEJpYmxpb3RlY2EgVmlydHVhbCBGR1YuCgo2LiBDYXNvIGEgT2JyYSBvcmEgZGVwb3NpdGFkYSBlbmNvbnRyZS1zZSBsaWNlbmNpYWRhIHNvYiB1bWEgbGljZW7Dp2EKQ3JlYXRpdmUgQ29tbW9ucyAocXVhbHF1ZXIgdmVyc8OjbyksIHNvYiBhIGxpY2Vuw6dhIEdOVSBGcmVlCkRvY3VtZW50YXRpb24gTGljZW5zZSAocXVhbHF1ZXIgdmVyc8OjbyksIG91IG91dHJhIGxpY2Vuw6dhIHF1YWxpZmljYWRhCmNvbW8gbGl2cmUgc2VndW5kbyBvcyBjcml0w6lyaW9zIGRhIERlZmluaXRpb24gb2YgRnJlZSBDdWx0dXJhbCBXb3JrcwooZGlzcG9uw612ZWwgZW06IGh0dHA6Ly9mcmVlZG9tZGVmaW5lZC5vcmcvRGVmaW5pdGlvbikgb3UgRnJlZSBTb2Z0d2FyZQpEZWZpbml0aW9uIChkaXNwb27DrXZlbCBlbTogaHR0cDovL3d3dy5nbnUub3JnL3BoaWxvc29waHkvZnJlZS1zdy5odG1sKSwgCm8gYXJxdWl2byByZWZlcmVudGUgw6AgT2JyYSBkZXZlIGluZGljYXIgYSBsaWNlbsOnYSBhcGxpY8OhdmVsIGVtCmNvbnRlw7pkbyBsZWfDrXZlbCBwb3Igc2VyZXMgaHVtYW5vcyBlLCBzZSBwb3Nzw612ZWwsIHRhbWLDqW0gZW0gbWV0YWRhZG9zCmxlZ8OtdmVpcyBwb3IgbcOhcXVpbmEuIEEgaW5kaWNhw6fDo28gZGEgbGljZW7Dp2EgYXBsaWPDoXZlbCBkZXZlIHNlcgphY29tcGFuaGFkYSBkZSB1bSBsaW5rIHBhcmEgb3MgdGVybW9zIGRlIGxpY2VuY2lhbWVudG8gb3Ugc3VhIGPDs3BpYQppbnRlZ3JhbC4KCgpBbyBjb25jbHVpciBhIHByZXNlbnRlIGV0YXBhIGUgYXMgZXRhcGFzIHN1YnNlccO8ZW50ZXMgZG8gcHJvY2Vzc28gZGUKc3VibWlzc8OjbyBkZSBhcnF1aXZvcyDDoCBCaWJsaW90ZWNhIFZpcnR1YWwgRkdWLCB2b2PDqiBhdGVzdGEgcXVlIGxldSBlCmNvbmNvcmRhIGludGVncmFsbWVudGUgY29tIG9zIHRlcm1vcyBhY2ltYSBkZWxpbWl0YWRvcywgYXNzaW5hbmRvLW9zCnNlbSBmYXplciBxdWFscXVlciByZXNlcnZhIGUgbm92YW1lbnRlIGNvbmZpcm1hbmRvIHF1ZSBjdW1wcmUgb3MKcmVxdWlzaXRvcyBpbmRpY2Fkb3Mgbm8gaXRlbSAxLCBzdXByYS4KCkhhdmVuZG8gcXVhbHF1ZXIgZGlzY29yZMOibmNpYSBlbSByZWxhw6fDo28gYW9zIHByZXNlbnRlcyB0ZXJtb3Mgb3UgbsOjbwpzZSB2ZXJpZmljYW5kbyBvIGV4aWdpZG8gbm8gaXRlbSAxLCBzdXByYSwgdm9jw6ogZGV2ZSBpbnRlcnJvbXBlcgppbWVkaWF0YW1lbnRlIG8gcHJvY2Vzc28gZGUgc3VibWlzc8Ojby4gQSBjb250aW51aWRhZGUgZG8gcHJvY2Vzc28KZXF1aXZhbGUgw6AgYXNzaW5hdHVyYSBkZXN0ZSBkb2N1bWVudG8sIGNvbSB0b2RhcyBhcyBjb25zZXHDvMOqbmNpYXMgbmVsZQpwcmV2aXN0YXMsIHN1amVpdGFuZG8tc2UgbyBzaWduYXTDoXJpbyBhIHNhbsOnw7VlcyBjaXZpcyBlIGNyaW1pbmFpcyBjYXNvCm7Do28gc2VqYSB0aXR1bGFyIGRvcyBkaXJlaXRvcyBhdXRvcmFpcyBwYXRyaW1vbmlhaXMgZS9vdSBjb25leG9zCmFwbGljw6F2ZWlzIMOgIE9icmEgZGVwb3NpdGFkYSBkdXJhbnRlIGVzdGUgcHJvY2Vzc28sIG91IGNhc28gbsOjbyB0ZW5oYQpvYnRpZG8gcHLDqXZpYSBlIGV4cHJlc3NhIGF1dG9yaXphw6fDo28gZG8gdGl0dWxhciBwYXJhIG8gZGVww7NzaXRvIGUKdG9kb3Mgb3MgdXNvcyBkYSBPYnJhIGVudm9sdmlkb3MuCgoKUGFyYSBhIHNvbHXDp8OjbyBkZSBxdWFscXVlciBkw7p2aWRhIHF1YW50byBhb3MgdGVybW9zIGRlIGxpY2VuY2lhbWVudG8gZQpvIHByb2Nlc3NvIGRlIHN1Ym1pc3PDo28sIGVudHJlIGVtIGNvbnRhdG8gY29tIFtuY2VwZ2VAZmd2LmJyXQo= |
dc.title.por.fl_str_mv |
Licença compulsória para medicamentos como política pública: o caso do anti-retroviral efavirenz |
title |
Licença compulsória para medicamentos como política pública: o caso do anti-retroviral efavirenz |
spellingShingle |
Licença compulsória para medicamentos como política pública: o caso do anti-retroviral efavirenz Hoirisch, Cláudia Licença compulsória Efavirenz Terapia anti-retroviral de alta efetividade (TARV) Medicamentos Acesso a medicamentos Orçamento Capacitação tecnológica Propriedade intelectual Patentes Compulsory licensing Efavirenz Highly Active AntiRetroviral Treatment (HAART) Drugs Access to medicines Budget Technological capability Intellectual property Patents Brazil Administração de empresas Políticas públicas Patentes Medicamentos Propriedade industrial |
title_short |
Licença compulsória para medicamentos como política pública: o caso do anti-retroviral efavirenz |
title_full |
Licença compulsória para medicamentos como política pública: o caso do anti-retroviral efavirenz |
title_fullStr |
Licença compulsória para medicamentos como política pública: o caso do anti-retroviral efavirenz |
title_full_unstemmed |
Licença compulsória para medicamentos como política pública: o caso do anti-retroviral efavirenz |
title_sort |
Licença compulsória para medicamentos como política pública: o caso do anti-retroviral efavirenz |
author |
Hoirisch, Cláudia |
author_facet |
Hoirisch, Cláudia |
author_role |
author |
dc.contributor.unidadefgv.por.fl_str_mv |
Escolas::EBAPE |
dc.contributor.member.none.fl_str_mv |
Teixeira, Sônia Maria Fleury Chamas, Claudia Inês |
dc.contributor.author.fl_str_mv |
Hoirisch, Cláudia |
dc.contributor.advisor1.fl_str_mv |
Saravia, Enrique J. |
contributor_str_mv |
Saravia, Enrique J. |
dc.subject.por.fl_str_mv |
Licença compulsória Efavirenz Terapia anti-retroviral de alta efetividade (TARV) Medicamentos Acesso a medicamentos Orçamento Capacitação tecnológica Propriedade intelectual Patentes |
topic |
Licença compulsória Efavirenz Terapia anti-retroviral de alta efetividade (TARV) Medicamentos Acesso a medicamentos Orçamento Capacitação tecnológica Propriedade intelectual Patentes Compulsory licensing Efavirenz Highly Active AntiRetroviral Treatment (HAART) Drugs Access to medicines Budget Technological capability Intellectual property Patents Brazil Administração de empresas Políticas públicas Patentes Medicamentos Propriedade industrial |
dc.subject.eng.fl_str_mv |
Compulsory licensing Efavirenz Highly Active AntiRetroviral Treatment (HAART) Drugs Access to medicines Budget Technological capability Intellectual property Patents Brazil |
dc.subject.area.por.fl_str_mv |
Administração de empresas |
dc.subject.bibliodata.por.fl_str_mv |
Políticas públicas Patentes Medicamentos Propriedade industrial |
description |
The scope of this study is to evaluate the implementation process of the Compulsory License in the case of the antiretroviral efavirenz. This research is descriptive in nature and the medium of investigation was the case study. It was conducted during the months of October through December 2009 with semi-structured interviews containing open-ended questions with a group of Public Health policy makers and managers residing in the states of Rio de Janeiro, Sao Paulo and the Federal District who participated in the compulsory license process. These individuals were allowed to express themselves without any constraints in such a way that they could produce discourses. The Collective Subject Discourse (CSD) technique was then used for analysis of the discourses. The results revealed that Brazil has the technological capability to develop and produce antiretrovirals within a reasonably short period of time. The results further showed that the Compulsory License helped to curb spending on antiretrovirals and that the measure can be used to ensure access by the public to high-cost and strategic antiretroviral drugs for the Brazilian public health service (Unified Health System – SUS) in an environment with limited funds, whenever an impasse is reached in negotiations for price reductions with transnational pharmaceutical laboratories. |
publishDate |
2010 |
dc.date.accessioned.fl_str_mv |
2010-05-14T12:29:32Z |
dc.date.available.fl_str_mv |
2010-05-14T12:29:32Z |
dc.date.issued.fl_str_mv |
2010-03-24 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
HOIRISCH, Cláudia. Licença compulsória para medicamentos como política pública: o caso do anti-retroviral efavirenz. Dissertação (Mestrado em Gestão Empresarial) - FGV - Fundação Getúlio Vargas, Rio de Janeiro, 2010. |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10438/6559 |
identifier_str_mv |
HOIRISCH, Cláudia. Licença compulsória para medicamentos como política pública: o caso do anti-retroviral efavirenz. Dissertação (Mestrado em Gestão Empresarial) - FGV - Fundação Getúlio Vargas, Rio de Janeiro, 2010. |
url |
http://hdl.handle.net/10438/6559 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional do FGV (FGV Repositório Digital) instname:Fundação Getulio Vargas (FGV) instacron:FGV |
instname_str |
Fundação Getulio Vargas (FGV) |
instacron_str |
FGV |
institution |
FGV |
reponame_str |
Repositório Institucional do FGV (FGV Repositório Digital) |
collection |
Repositório Institucional do FGV (FGV Repositório Digital) |
bitstream.url.fl_str_mv |
https://repositorio.fgv.br/bitstreams/52573174-8e73-4767-8224-1f8e831ff7b6/download https://repositorio.fgv.br/bitstreams/9d0487a2-697f-40cf-87af-05093b5ab97f/download https://repositorio.fgv.br/bitstreams/5ce0667e-0fe7-418a-931c-bb140249826b/download https://repositorio.fgv.br/bitstreams/3b134e28-12e3-4128-ba39-ac831ec62daf/download |
bitstream.checksum.fl_str_mv |
18921b0201a6008cb606c1dcc39797a0 4dea6f7333914d9740702a2deb2db217 f33a98bc8615ba283e947359a1dcbf3b 57a8307b2ca767aa36af916d78eb81e8 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional do FGV (FGV Repositório Digital) - Fundação Getulio Vargas (FGV) |
repository.mail.fl_str_mv |
|
_version_ |
1819893208691245056 |